CIT-013 medium dose clinical trials

A Study With CIT-013 in HS Patients

This study is testing a new medicine called CIT-013 for adults with Hidradenitis Suppurativa (HS), a skin condition. Researchers want to see if CIT-013 helps reduce HS symptoms and if it's safe. It's a Phase 2 trial comparing different doses of CIT-013 to a dummy medicine.